Product Information
VENLAFAXINE HCL ER 150 MG TAB is a generic product labeled by BluePoint Laboratories, priced at $0.2277 per EA under NDC 68001049804. Its NADAC has been published 257 times since Nov 3, 2021.
FDA first approved this application on Oct 21, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001049804
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214419FDA Approved
10/21/2020
TE Code
AB
On Market Since
4/30/2021
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 150 MG TAB has been published 257 times since Nov 3, 2021, and over the history we have for it it has declined 89.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2277 per EA |
|---|---|
| All-time high | $3.1035 (Jan 12, 2022) |
| All-time low | $0.1711 (May 22, 2024) |
| 52-week high | $0.3110 |
| 52-week low | $0.2085 |
| Median price | $0.2584 |
| Average price | $0.6544 |
| Largest weekly change | +83.6% (Jun 19, 2024) |
| Weeks tracked | 257 |
| Tracking since | Nov 3, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BluePoint Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
venlafaxine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin and Norepinephrine Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 150 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 150 MG TAB, manufactured by BluePoint Laboratories, is $0.2277 per EA (NDC 68001049804), effective Sep 30, 2026.
How has the price of VENLAFAXINE HCL ER 150 MG TAB changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 150 MG TAB has declined 89.0%. It has been tracked across 257 weekly CMS publications since Nov 3, 2021.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 150 MG TAB?
Since Nov 3, 2021, the NADAC for VENLAFAXINE HCL ER 150 MG TAB has ranged from a low of $0.1711 (May 22, 2024) to a high of $3.1035 (Jan 12, 2022), with a median of $0.2584 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 150 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VENLAFAXINE HCL ER 150 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL ER 150 MG TAB?
VENLAFAXINE HCL ER 150 MG TAB (NDC 68001049804) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.